Alexion Appoints Judith A. Reinsdorf, JD, to its Board of Directors - Digital Journal -BoardProspects

Alexion Appoints Judith A. Reinsdorf, JD, to its Board of Directors

Digital Journal Feb 5 2018 BoardMoves

NEW HAVEN, Conn.--(Business Wire)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Judith A. Reinsdorf, J.D., has been appointed to the Company's Board of Directors . Ms. Reinsdorf is an accomplished executive with a strong background in corporate governance and broad ...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Dune Energy Appoints Two New Directors, Marjorie Bowen And John Brecker also published in Digital Journal
- Intel CEO to retire as chipmaker struggles with mobile also categorized in BoardMoves
- Proxy season results show dramatic shift in company-shareholder engagement also published in Digital Journal
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Yahoo co-founder David Filo nominated for company's new board member also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Quotes
1. I am excited to join Alexion's Board of Directors at a pivotal time for the Company as it executes on a strategy to deliver sustainable growth and strengthens its leadership position in rare diseases. I look forward to applying my experience to help guide Alexion's future success.
Topics Mentioned